Henan Taloph Pharmaceutical Stock Co.,Ltd.’s Net Profit Rose 51.8% in First Quarter of 2023

Henan Taloph Pharmaceutical Stock Co.,Ltd. (河南太龙药业股份有限公司) (600222.SH) reported a net profit of 3.3 million yuan in the first quarter of 2023, up 51.8% year-on-year.

Meanwhile, the company posted 560.3 million yuan in revenue, up 32.7% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 2 billion yuan in total liabilities, with a liability-to-asset ratio of 55.3%.